Morgan Stanley raised the firm’s price target on CME Group (CME) to $263 from $256 and keeps an Equal Weight rating on the shares. In a model refresh following Q4 results, the firm is raising its 2025 adjusted EPS view by 3.6% to $10.97 from $10.59.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME: